Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACC 2020
Biotech
Praluent sidekick halves cholesterol—even in hard-to-treat group
Regeneron's latest cholesterol fighter cut "bad" cholesterol in half for patients with a rare genetic disorder, including in hard-to-treat patients.
Amirah Al Idrus
Mar 30, 2020 11:45am
MyoKardia cuts heart stress signs in biomarker study
Mar 30, 2020 10:30am
10-year stent data similar to CABG, but less durable
Mar 30, 2020 9:00am
Medtronic's kidney device sees drops in high blood pressure
Mar 29, 2020 11:45am
Edwards' TAVR safety equal to open surgery after 2 years
Mar 29, 2020 9:00am
Novartis presents pooled inclisiran data cutting LDL by 51%
Mar 28, 2020 2:31pm
